Compare GROW & BTMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | GROW | BTMD |
|---|---|---|
| Founded | 1968 | 2012 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Investment Managers | Medicinal Chemicals and Botanical Products |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 32.7M | 39.0M |
| IPO Year | 1995 | 2021 |
| Metric | GROW | BTMD |
|---|---|---|
| Price | $2.87 | $1.17 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 5 |
| Target Price | N/A | ★ $2.61 |
| AVG Volume (30 Days) | 20.3K | ★ 140.1K |
| Earning Date | 11-11-2026 | 11-04-2026 |
| Dividend Yield | ★ 3.13% | N/A |
| EPS Growth | ★ 900.00 | 722.22 |
| EPS | ★ 0.24 | N/A |
| Revenue | $14,399,000.00 | ★ $192,219,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $5.45 |
| P/E Ratio | $12.13 | ★ N/A |
| Revenue Growth | ★ 32.77 | N/A |
| 52 Week Low | $2.23 | $1.15 |
| 52 Week High | $3.65 | $3.26 |
| Indicator | GROW | BTMD |
|---|---|---|
| Relative Strength Index (RSI) | 36.43 | 31.58 |
| Support Level | $2.47 | N/A |
| Resistance Level | $2.88 | $1.68 |
| Average True Range (ATR) | 0.09 | 0.07 |
| MACD | -0.01 | 0.00 |
| Stochastic Oscillator | 0.00 | 17.19 |
US Global Investors Inc is a registered investment advisory firm. The company manages the following business segments: Investment management services; through which the company offers, to U.S. Global Investors Funds (USGIF or the Funds) and exchange-traded fund (ETF) clients, a range of investment management products and services to meet the needs of individual and institutional investors; and Corporate Investments, through which the company invests for its own account in an effort to add growth and value to its cash position. It derives all its revenue from Investment management services.
Biote Corp operates a growth practice-building business within the hormone optimization space. It provides the necessary components to enable Biote-certified practitioners to establish, build, and successfully implement a program designed to optimize hormone levels using personalized solutions for their patient populations. The company provides support to medical practitioners through training, practice development, and operational services to establish and manage hormone therapy centers. Its activities include educating practitioners on identifying and treating hormone-related conditions. The company generates revenues by charging the Biote-partnered clinics fees associated with the Biote Method and from the sale of Biote-branded dietary supplements.